510(k) · Cleared
ClearedAbClose - Port Site Closure Device
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Medeon Biodesign, Inc. · OCW Endoscopic Tissue Approximation Device
Cleared on Mar 26, 2020 as substantially equivalent to K160117 (Medeon Biodesign, Inc., 2016) after an 87-day review. Its family tree reaches back 3 generations to 2010.
- Decided
- Mar 26, 2020
- Review
- 87 days
- Class
- Class II
- Product code
- OCW
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 3 generations to K103412 (2010). No later device cites it as a predicate yet.
- Root · 3 generations backK103412 Axiom Fascial Closure SystemAxiom Technology Partners, LLC · 2010
- 2 generations backK132362 Weck Efx Endo Fascial Closure SystemTeleflexmedical, Inc. · 2013
- 1 generation backK160117 AbClose - Port Site Closure DeviceMedeon Biodesign, Inc. · 2016
- This deviceK193652 AbClose - Port Site Closure DeviceMedeon Biodesign, Inc. · 2020
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K103412 | Axiom Fascial Closure System | Axiom Technology Partners, LLC | 2010 | — |
| −2 | K132362 | Weck Efx Endo Fascial Closure System | Teleflexmedical, Inc. | 2013 | — |
| −1 | K160117 | AbClose - Port Site Closure Device | Medeon Biodesign, Inc. | 2016 | — |
| 0 (this device) | K193652 | AbClose - Port Site Closure Device | Medeon Biodesign, Inc. | 2020 | — |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in OCW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new OCW device
- #1 K252400 Endomina EZFuse systemscore 12.0 · 5 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K160117 | AbClose - Port Site Closure DeviceSummary page 4…CFR Part 876.1500 Classification Device Class II Classification Gastroenterology/Urology Panel 3 Predicate k K160117 number 4 Device The AbCloseTM - Port Site Closure Device is a sterile, single-use Description: devi… | 2016 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 10 years and passes through 3 companies; a new generation was cleared every 2.9 years on median.
- None of the 3 ancestors has a recall.
How does its category compare?
All OCW devicesOCW Endoscopic Tissue Approximation Device: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.
FDA decisions per year · OCW
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · OCW
133in 2023
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · OCW
3so far in 2026, the most since 2007
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · OCW
326in 2025
MAUDE reports naming product code OCW, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 5 | 58 | 0 | 9 |
| 2008 | 4 | 70 | 0 | 47 |
| 2009 | 3 | 30 | 0 | 30 |
| 2010 | 4 | 91 | 0 | 10 |
| 2011 | 1 | — | 0 | 16 |
| 2012 | 1 | — | 0 | 28 |
| 2013 | 2 | — | 0 | 2 |
| 2014 | 0 | — | 0 | 28 |
| 2015 | 0 | — | 0 | 59 |
| 2016 | 2 | — | 0 | 74 |
| 2017 | 2 | — | 0 | 420 |
| 2018 | 2 | — | 0 | 413 |
| 2019 | 1 | — | 0 | 291 |
| 2020 | 1 | — | 0 | 183 |
| 2021 | 3 | 221 | 0 | 198 |
| 2022 | 0 | — | 0 | 235 |
| 2023 | 3 | 133 | 1 | 227 |
| 2024 | 0 | — | 0 | 211 |
| 2025 | 1 | — | 0 | 326 |
| 2026 | 2 | — | 3 | — |
What is it indicated for?
The AbClose - Port Site Closure Device has application in laparoscopic procedures for approximation of tissues and
percutaneous suturing for closing incision sites.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K193652 · printed Nov 5, 2026
Cite this page
510(k) Report. “K193652: AbClose - Port Site Closure Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K193652
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026